
    
      Patients who diagnosed as BPH with moderate to severe LUTS aged 20 to 80 years old will be
      divided into two groups, one is moxibustion plus conventional therapy group and the other is
      conventional therapy group.

      Patients who belong to moxibustion plus conventional therapy group will be treated
      moxibustion for eight times by a Korean Medicine doctor with conventional therapy by a
      urologist.

      Patients who belong to conventional therapy group will be treated with conventional therapy
      only, and they can receive moxibustion therapy after the clinical trial is finished.

      IPSS, post void residual volume (PVR) and peak urine flow (Qmax) will be checked to evaluate
      the effectiveness and safety.
    
  